Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMQS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,794
Award facts
- Contract value 100% obligated
- $61,794.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $61,794.48 by the Defense Logistics Agency on January 12, 2026. This firm fixed-price delivery order, issued without a set-aside designation, is for pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award represents performance under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for military medical facilities.
DMS Pharmaceutical Group's product portfolio includes branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals. The company holds a single-award IDC under the PPV-G GEN V program with a $499,999,999 ceiling value and completion date of December 31, 2036, positioning it as a critical regional pharmaceutical supplier for the Department of Defense's global medical supply requirements. The delivery order is scheduled for completion by January 13, 2026, and will be performed in Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DU26FEMQS?
SPE2DU26FEMQS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FEMQS worth?
The government has obligated $61,794 on SPE2DU26FEMQS.
Is contract SPE2DU26FEMQS an order under another contract?
Yes. SPE2DU26FEMQS is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMQS competed?
The extent of competition for SPE2DU26FEMQS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award